CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
What does an index reading tell you about the market? It reflects price action and momentum, offering clues to potential trends and turning points.
28,481 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
Investing in AI can feel like riding a hype wave. This article digs into what makes a stock a true money-maker, unvei...
AI stocks have run hot, but some Wall Street analysts see big downside. Here are two names in the artificial intellig...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...
XRP has repeatedly rebounded despite jitters in the crypto space. This article uncovers the real reason keeps bouncin...
Wix faced a sharp stock drop after its quarterly results and cautious analyst notes. This article breaks down the fac...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
A tectonic shift is quietly unfolding in mobility and AI. The trillion robotaxi boom real could power a new era of ea...
Hot IPOs and rapid meme stocks grab headlines, but durable income and resilience win long games. Here are three stock...
A wave of selling from retail investors has pulled Wendy's stock lower. This guide explains why that crowd dynamic co...